Delivery Order SPE2DR25D1004-SPE2DR26FSVK8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,472.09 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on September 19, 2025, with completion expected by September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance and reliever inhaler used in the...
- The Defense Logistics Agency awarded a $13,124.13 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a completion date of December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhalation medication used to treat chronic obstructive pulmonary disease and asthma,...
- The Defense Logistics Agency awarded a delivery order valued at $1,211.94 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count package) on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price, competitively awarded delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhalation treatment for chronic...
- The Defense Logistics Agency awarded a delivery order valued at $7,178.56 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a prescription maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.62 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive...
- The Defense Logistics Agency awarded a $1,492.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $4,415.80 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used for chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $5,007.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used for chronic...
- The Defense Logistics Agency awarded a delivery order valued at $12,543.10 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This firm fixed price, non-competitive delivery order is scheduled for completion by January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhaler containing fluticasone, umeclidinium, and vilanterol,...
- The Defense Logistics Agency awarded a $50,202.47 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a completion date of December 30, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive pulmonary disease and...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSVK8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,796.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive pulmonary disease and asthma, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military medical supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp leverages this strategic contract vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating its critical role in sustaining military medical readiness and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 11/23/25 |